Full-Time

VP – Life Sciences

Confirmed live in the last 24 hours

Iterative Health

Iterative Health

51-200 employees

AI-driven solutions for gastrointestinal care

AI & Machine Learning
Healthcare

Senior, Expert

Remote in USA

Category
Lab & Research
Life Sciences
Required Skills
Sales
Requirements
  • Deep network of biopharma / biotech contacts and relationships across clinical research, development and operations
  • Experience in an MSL, medical affairs or clinical operations role at a biopharma/biotech or CRO
  • Sales-minded individual with experience carrying multi-million dollar books of business
  • Experience across gastroenterology and/or hepatology
  • Experience and interest in people management
  • Aptitude for collaborating cross-functionally to drive business growth
  • Strong written/verbal and external communication and interpersonal skills
Responsibilities
  • Drive pipeline of CTO development, including pitching and positioning capabilities, pricing, negotiations, etc.
  • Engage existing partners to ensure the success of current projects, as well as develop new growth areas
  • Partner with internal staff and external leaders to provide direction, answer questions, and resolve issues related to trials strategy
  • Participate in CTO leadership meetings and translate strategic objectives into operational execution

Iterative Health focuses on improving gastrointestinal (GI) care through the use of artificial intelligence (AI) and machine learning (ML). Their main product, SKOUT®, is an FDA-cleared device designed to help doctors detect adenomas, which are precursors to colorectal cancer. This device works alongside physician judgment to enhance the accuracy of diagnoses. In addition to SKOUT®, Iterative Health provides services that optimize clinical trials by using AI-enabled documentation technology, which improves patient care and ensures high-quality reporting across different healthcare institutions. This technology aims to make advanced care more accessible, especially to underserved populations. Unlike many competitors, Iterative Health combines AI technology with a strong focus on colorectal cancer prevention and clinical trial efficiency. The company's goal is to deliver top-tier GI care and improve patient outcomes globally.

Company Stage

Series B

Total Funding

$182.1M

Headquarters

Boston, Massachusetts

Founded

2017

Growth & Insights
Headcount

6 month growth

-6%

1 year growth

-16%

2 year growth

-24%
Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven predictive analytics in gastroenterology allow for personalized, effective patient care.
  • Integration of AI in endoscopy improves detection rates, enhancing SKOUT® device effectiveness.
  • AI-based recruitment tools increase efficiency and success rates of IBD clinical trials.

What critics are saying

  • Competition from tech giants in AI medical imaging threatens Iterative Health's market share.
  • Rapid expansion and partnerships may strain Iterative Health's operational capabilities and resources.
  • Reliance on AI exposes Iterative Health to potential biases, affecting diagnosis accuracy and trust.

What makes Iterative Health unique

  • Iterative Health uses AI to enhance GI care, focusing on colorectal cancer prevention.
  • Their SKOUT® device is FDA cleared for adenoma detection, aiding in accurate diagnoses.
  • AI-enabled documentation technology optimizes clinical trials, improving patient care quality and continuity.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Vision/Dental/ Medical Insurance

Life/Disability Insurance

Parental Leave

Stock Options

Flexible Work Hours

Unlimited Paid Time Off